Merrimack Pharmaceuticals
MACK
#7959
Rank
NZ$0.38 B
Marketcap
$26.16
Share price
0.00%
Change (1 day)
22.62%
Change (1 year)

Merrimack Pharmaceuticals (MACK) - Cash on Hand

Cash on Hand as of March 2024 : NZ$0.42 Billion

According to Merrimack Pharmaceuticals's latest financial reports the company has NZ$0.42 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Merrimack Pharmaceuticals - Cash on Hand chart (from 2010 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$29.84 M-2.52%
2022-12-31NZ$30.61 M47.24%
2021-12-31NZ$20.79 M6.88%
2020-12-31NZ$19.45 M-20.97%
2019-12-31NZ$24.61 M-76.83%
2018-12-31NZ$0.10 B-19.23%
2017-12-31NZ$0.13 B323.42%
2016-12-31NZ$31.07 M-88.54%
2015-12-31NZ$0.27 B71.32%
2014-12-31NZ$0.15 B-16.19%
2013-12-31NZ$0.18 B41.31%
2012-12-31NZ$0.13 B106.75%
2011-12-31NZ$64.64 M62.39%
2010-12-31NZ$39.81 M-50.48%
2009-12-31NZ$80.38 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$12.59 B 2,883.95%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$0.13 B-68.29%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.58 B 39.19%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.10 B-76.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.37 M-98.25%๐Ÿ‡บ๐Ÿ‡ธ USA